Find More Contacts for Endocyte
Protected Content
Director
1 email found
View contacts for Endocyte to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email info@endocyte.com
  • Phone Number (765) 463-7175

Endocyte, Inc., a biopharmaceutical company, develops receptor-targeted therapeutics to treat cancer and autoimmune/inflammatory diseases. The company provides EC17, a folate-targeted hapten therapy drug to treat metastatic renal and ovarian cancer; EC145, a folate-targeted chemotherapeutic conjugate to treat various tumors, including cancers

of the breast, lung, and blood; EC0225, a targeted chemotherapy drug; BMS753493, a folate-targeted anti-cancer therapy drug; EC0434 to target folate receptor positive tumors; and EC0305, an anti-cancer therapy drug. It also offers EC0286, a folate-targeted small molecule for the treatment of inflammatory diseases; and EC20, a folate-targeted radiopharmaceutical imaging agent to identify folate-receptor positive cancers. The company was founded in 1996 and is based in West Lafayette, Indiana.

Lists Featuring This Company

Great Lakes Companies that Exited (Top 10K)
9,997 Number of Organizations â€¢ $519.2B Total Funding Amount â€¢ 10,363 Number of Investors
Acquired Midwestern US Companies (Top 10K)
9,910 Number of Organizations â€¢ $140.8B Total Funding Amount â€¢ 5,489 Number of Investors
Closed United States Health Care Companies
6,886 Number of Organizations â€¢ $67.6B Total Funding Amount â€¢ 6,738 Number of Investors
Closed United States Companies (Top 10K)
9,793 Number of Organizations â€¢ $232.9B Total Funding Amount â€¢ 31,088 Number of Investors
Endocyte was acquired by Novartis on Oct 18, 2018.

Frequently Asked Questions

Where is Endocyte's headquarters? Endocyte is located in West Lafayette, Indiana, United States.Who invested in Endocyte? Endocyte has 11 investors including MidCap Financial and Silicon Valley Bank.How much funding has Endocyte raised to date? Endocyte has raised .When was the last funding round for Endocyte? Endocyte closed its last funding round on Dec 27, 2010 from a Debt Financing round.Who are Endocyte's competitors? Alternatives and possible competitors to Endocyte may include Inovio PharmaceuticalsSoligenix, and Apogenix.